← Back to Patent Explorer
US3140984A Expired / Lapsed US ⏱️ 0.0 years remaining

Production of high activity fibrinolytic agents

Assignee: University of Alberta
•
Filing: 1961-11-30
•
Granted: 1964-07-14
•
Expires: 1981-11-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Fibrinolytic material produced from Aspergillus Oryzal B1273 has blood pressure lowering agents removed therefrom by filtering the material through a cross-linked dextran having a water regain value of substantially 5 grams per gram and particle size 50-270 mesh dry basis, U.S. Standard Sieves. The filter may be developed with an eluting agent such as hydrochloride acid of pH 3.5 to 5.5 and the fractions of high fibrinolytic activity pooled and dried in vacuo from the frozen state.ALSO:Fibrinolytic material produced from Aspergillus oryz B1273 has blood pressure lowering agents removed therefrom by filtering the material through a cross-linked dextran having a water regain value of substantially 5 grams per gram and particle size 50-270 mesh dry basis, U.S. standard sieves. The filter may be developed with an eluting agent such as hydrochloric acid of pH 3.5 to 5.5 and the fractions of high fibrinolytic activity pooled and dried in vacuo from the frozen state.

Inventors

  • 👤 Anthony L Tosoni
  • 👤 David A J Ives

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 10:57
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/58; C12N9/62; A; A61; A61K; A61K36/00; A61K36/06; A61K36/062; Y; Y10; Y10S; Y10S435/00; Y10S435/814; Y10S435/815

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 53 words
A PROCESS FOR PURIFYING FIBRINOLYTIC MATERIAL PRODUCED FROM ASPERGILLUS ORYZAE B1273 AND REMOVING BLOOD PRESSURE LOWERING AGENTS THEREFROM CONSISTING IN FILTERING AN AQUEOUS SOLUTION OF SAID FIBRINOLYTIC MATERIAL THROUGH CROSS-LINKED DEXTRAN KNOWN AS SEPHADEX G50 DEVELOPING THE FILTER WITH AN ELUTING AGENT AND COLLECTING THE ELUATE WHEN CONTAINS THE DESIRED RESULTING FIBRINOLYTIC MATERIAL.
Claim 2
Dependent Claim 53 words
A PROCESS FOR PURIFYING FIBRINOLYTIC MATERIAL PRODUCED FROM ASPERGILLUS ORYZAE B1273 AND REMOVING BLOOD PRESSURE LOWERING AGENTS THEREFROM CONSISTING IN FILTERING AN AQUEOUS SOLUTION OF SAID FIBRINOLYTIC MATERIAL THROUGH CROSS-LINKED DEXTRAN KNOWN AS SEPHADEX G50 DEVELOPING THE FILTER WITH AN ELUTING AGENT AND COLLECTING THE ELUATE WHEN CONTAINS THE DESIRED RESULTING FIBRINOLYTIC MATERIAL.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1967-07-14 1968-01-13 1968-07-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1971-07-14 1972-01-13 1972-07-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1975-07-14 1976-01-13 1976-07-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag